ibudilast has been researched along with Brain Neoplasms in 2 studies
Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Alban, TJ | 1 |
Bayik, D | 1 |
Otvos, B | 1 |
Rabljenovic, A | 1 |
Leng, L | 1 |
Jia-Shiun, L | 1 |
Roversi, G | 1 |
Lauko, A | 1 |
Momin, AA | 1 |
Mohammadi, AM | 1 |
Peereboom, DM | 1 |
Ahluwalia, MS | 1 |
Matsuda, K | 2 |
Yun, K | 1 |
Bucala, R | 1 |
Vogelbaum, MA | 1 |
Lathia, JD | 1 |
Ha, W | 1 |
Sevim-Nalkiran, H | 1 |
Zaman, AM | 1 |
Khasraw, M | 1 |
Nowak, AK | 1 |
Chung, L | 1 |
Baxter, RC | 1 |
McDonald, KL | 1 |
2 other studies available for ibudilast and Brain Neoplasms
Article | Year |
---|---|
Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression.
Topics: Animals; Brain Neoplasms; Glioblastoma; Humans; Immunotherapy; Macrophage Migration-Inhibitory Facto | 2020 |
Ibudilast sensitizes glioblastoma to temozolomide by targeting Macrophage Migration Inhibitory Factor (MIF).
Topics: Aged; Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; DNA Methylation; DNA Modifi | 2019 |